Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
The gut microbiota in type 1 diabetes: friend or foe?Patrick G Gavin, Emma E Hamilton-Williams
Microbiome|December 16, 2022
Multi-omic interactions in the gut of children at the onset of islet autoimmunityPatrick G Gavin, Ki Wook Kim, Maria E Craig, et al.
British Journal of Cancer|December 15, 2017
Tumour sidedness and intrinsic subtypes in patients with stage II/III colon cancer: analysis of NSABP C-07 (NRG Oncology)S Rim Kim, Nan Song, Greg Yothers, et al.
BMC Cancer|March 18, 2010
A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodesDebora Fumagalli, Patrick G Gavin, Yusuke Taniyama, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Anifrolumab Treatment Leads to Rapid Reduction in Urinary Biomarkers of Intrarenal Inflammation in Lupus Nephritis: Results from the Phase 2 TULIP-LN TrialAndrea Fava, Michelle Petri, Patrick G Gavin, et al.
Diabetes Care|August 14, 2018
Intestinal Metaproteomics Reveals Host-Microbiota Interactions in Subjects at Risk for Type 1 DiabetesPatrick G Gavin, Jane A Mullaney, Dorothy Loo, et al.
Microbiome|February 19, 2018
Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiotaJane A Mullaney, Juliette E Stephens, Mary-Ellen Costello, et al.
Microbiome|March 22, 2018
Correction to: Type 1 diabetes susceptibility alleles are associated with distinct alterations in the gut microbiotaJane A Mullaney, Juliette E Stephens, Mary-Ellen Costello, et al.
Pageof 3